Specialists win award to examine why COVID-19 patients lose their feeling of smell Kumar Jeetendra | July 22, 2020 “The virus frequently begins in the nose prior to making its way to the lungs,” stated Diego Restrepo, PhD, professor of developmental and cell biology in the University of Colorado School of Medicine whose lab won the $125,000 grant from the National Institutes of Health late last month. “We believe this may spark an inflammatory …
Possible connect to brain irritation may clarify the association among MS and exhaustion Kumar Jeetendra | August 27, 2020 As much as 60 percent of individuals with multiple sclerosis (MS) report that fatigue is that the disease’s most distressing symptom. And fatigue remains among MS’s puzzles — despite its incidence and significance, the root cause of this symptom remains unclear. In a study published in Neurology Neuroimmunology & Neuroinflammation, investigators from Brigham and Women’s …
Parkinson’s disease is a free danger factor for biting the dust from COVID-19, study recommends Kumar Jeetendra | October 3, 2020 A fresh study of about 80,000 patients shows that people with Parkinson’s disease (PD) have a 30% greater risk of dying from COVID-19 than individuals without the neurodegenerative condition. The new analysis conducted by researchers at University of Iowa Health Care based on patient information in the TriNetX COVID-19 research network suggests that Parkinson’s disease …
Trial ALS drug shows potential to drag out patient endurance Kumar Jeetendra | October 18, 2020 An experimental medicine that was recently shown to slow the progression of the neurodegenerative disease amyotrophic lateral sclerosis (ALS), or Lou Gehrig’s disease, has now demonstrated the capacity to also prolong patient survival. The findings come from a clinical trial conducted by investigators at the Sean M. Healey & AMG Center for ALS at Massachusetts …
Gene therapy can viably treat mice with tuberous sclerosis complex, shows study Kumar Jeetendra | January 9, 2021 Patients with tuberous sclerosis complex, a genetic disorder characterized by the growth of noncancerous tumors in several organs of the body, have limited treatment choices. A team led by investigators at Massachusetts General Hospital (MGH) has shown that gene therapy can effectively treat mice that express one of the mutated genes that cause the disease. …
Study distinguishes top factor for life span in clinical research coordinator positions Kumar Jeetendra | March 6, 2021 Danielle Buchanan, BS, clinical translational research coordinator III in the Department of Neurology, and Daniel Claassen, MD, MS, chief of the Division of Psychological Disorders and associate professor of Neurology, found the top element for retention is a close working relationship between clinical research coordinators (CRCs) and the study’s principal investigator that emphasizes respect and …
Nintendo Wii treatment can help improve balance in children with cerebral paralysis Kumar Jeetendra | June 9, 2021 Therapy based on the Nintendo® Wii Balance Board can help improve balance in children with cerebral palsy, according to an investigation published in Developmental Medicine & Child Neurology. For the analysis, researchers from the University of Jaén, in Andalusia, Spain examined data from all relevant randomized controlled trial published to date. In 11 trials with …
Small molecule drug can weaken the triggers of neuroinflammation, preclinical review shows Kumar Jeetendra | September 24, 2021 Neuroinflammation may cause worse outcomes in cases of stroke, injuries to the brain or injury, and can increase the severity of neurodegenerative diseases such as ALS, Parkinson’s, or Alzheimer’s. This suggests that reducing neuroinflammation might be an exciting new method to treat neurological disorders and neuropathic pain caused by neuroinflammation. In a preclinical study , …